Gastroenterology
Volume 123, Issue 6 , Pages 1778-1785 , December 2002

Long-term improvement in functional dyspepsia using hypnotherapy

Received 3 May 2002 ,Accepted 27 August 2002.

References 

  1. Drossman DA, Li A, Andruzzi E, Temple RD, Talley NJ, Thompson WG, et al. householder survey of functional gastrointestinal disorders: prevalence, sociodemography and health impact. Dig Dis Sci. 1993;38:1569–1580
  2. Bommelaer G, Rouch M, Dapoigny M, Pais D, Loisy P, Gualino M, et al. Epidemiology of intestinal function disorders in apparently healthy people. Gastroenterol Clin Biol. 1986;10:7–12
  3. Talley NJ, Stanghelllini V, Heading RC, Koch KL, Malagelada JR, Tygat GNJ. Functional gastroduodenal disorders. In: 2nd ed.  Drossman DA,  Corazziari E,  Talley NJ,  Grant Thompson W,  Whitehead WE editor. Rome II: The functional gastrointestinal disorders. McLean, VA: Degnon Associates; 2000;
  4. Camilleri M, Phillips SF. Disorders of small intestinal motility. Gastroenterol Clin North Am. 1989;18:405–424
  5. Ness TJ, Metcalf AM, Gebhart GF. A psychophysical study in humans using colonic distension as a noxious visceral stimulus. Pain. 1990;43:377–386
  6. Mearin F, Cucala M, Azpiroz F, Malagelada JA. The origin of symptoms on the brain-gut axis in functional dyspepsia. Gastroenterology. 1991;101:999–1006
  7. Jones RH, Lydeard ST, Hobbs FDR, Kenkre JE, Williams EI, Jones SJ, et al. Dyspepsia in England and Scotland. Gut. 1990;31:401–405
  8. Talley NJ, Silverstein M, Agreus L, Nyren O, Sonnenberg A, Holtman G. AGA technical review: evaluation of dyspepsia. Gastroenterology. 1998;114:582–595
  9. Kurata JH. Gastritis/nonulcer dyspepsia. In:  Everhart JE editors. Digestive disease in the U.S.: epidemiology and impact. Washington, DC: National Institutes of Health, National Institute of Diabetes, Digestive and Kidney Diseases Publication; 1994;p. 94–1447 409
  10. Whorwell PJ, Prior A, Farragher EB. Controlled trial of hypnotherapy in the treatment of severe refractory irritable bowel syndrome. Lancet. 1984;2:1232–1234 1984
  11. Houghton LA, Heyman DJ, Whorwell PJ. Symptomatology, quality of life and economic features of irritable bowel syndrome—the effect of hypnotherapy. Aliment Pharmacol Ther. 1996;10:91–95
  12. Gonsalkorale WM, Houghton LA, Whorwell PJ. Hypnotherapy for irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness. Am J Gastroenterol. 2002;97:954–961
  13. Galvolski TE, Blanchard EB. The treatment of irritable bowel syndrome with hypnotherapy. Appl Psychophysiol Biofeedback. 1998;23:219–232
  14. Vidakovic-Vukic M. Hypnotherapy in the treatment of irritable bowel syndrome: methods and results in Amsterdam. Scand J Gastroenterol. 1999;(suppl 230):49–51
  15. Stacher G, Berner P, Naske R, Schuster P, Bauer P, Starker H, et al. Effect of hypnotic suggestion of relaxation on basal and betazole-stimulated gastric acid secretion. Gastroenterology. 1975;68:656–661
  16. Black S, Humphrey JH, Niven JSF. Inhibition of the Mantoux reaction by direct suggestion under hypnosis. Br Med J. 1963;I:1649–1651
  17. Prior A, Colgan SM, Whorwell PJ. Changes in rectal sensitivity after hypnotherapy in patients with irritable bowel syndrome. Gut. 1990;31:896–898
  18. Whorwell PJ, Houghton LA, Taylor E, Maxton DG. Physiological effects of emotion: assessment via hypnosis. Lancet. 1992;2:69–72
  19. Colin-Jones D. The management of dyspepsia. Scand J Gastroenterol. 1988;155:96–100
  20. Talley NJ, Janssens J, Laurilsen K, Racz I, Bolling-Sterneuald E. Eradication of Helicobacter pylori in functional dyspepsia: a randomised double-blind placebo-controlled trial with 12-months follow-up. BMJ. 1999;318:833–837
  21. Blum AL, Talley NJ, O'Morain C, VanZanten SV, Labenz J, Stolte M, et al. Lack of effect of treating Helicobacter pylori infection in patients with non-ulcer dyspepsia. N Engl J Med. 1998;339:1875–1881
  22. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11:395–402
  23. Dunbar GC, Stoker MJ, Hodges TCP, Beaumont G. The development of SBQOL: a unique scale for measuring quality of life. Br J Health Econ. 1992;2:65–74
  24. Gonsalkorale WM, Cruickshanks P, Whelan V, Miller V, Randles J, Cooper P, et al. Improvement in symptoms with hypnotherapy is associated with cognitive change. Gastroenterology. 2000;118:A616; (abstr)
  25. Gonsalkorale WM, Miller V, Afzal A, Whorwell PJ. Hypnotherapy for irritable bowel syndrome: improvement is long-lasting and reduces health care costs. Gastroenterology. 2002;122:A69; (abstr)
  26. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–370
  27. Whorwell PJ. Hypnosis and the gastrointestinal system. Br J Hosp Med. 1991;45:27–29
  28. Begg C, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, et al. Improving the quality of reporting of randomised controlled trials. The CONSORT statement. JAMA. 1996;276:637–639

☆ Address requests for reprints to: Peter J. Whorwell, M.D., Department of Medicine, Education and Research Centre, Wythenshawe Hospital, Southmoor Road, Manchester M23 9LT, United Kingdom. e-mail: peter.whorwell@smuht.nwest.nhs.uk; fax: (44) 161-434-5194.

☆☆ Supported by a grant from the Wellcome Trust.

PII: S0016-5085(02)00449-3

doi: 10.1053/gast.2002.37071

Gastroenterology
Volume 123, Issue 6 , Pages 1778-1785 , December 2002

Article Tools

* Image Usage & Resolution